Morphological profiling in human neural progenitor cells classifies hits in a pilot drug screen for Alzheimer's disease.

导出 LinkOut

翻译打印收藏纠错

作者： Amina H,McDiarmid ^[1] ; Katerina O,Gospodinova ^[1] ; Richard J R,Elliott ^[2] ; John C,Dawson ^[2] ; Rebecca E,Graham ^[2] ; Marie-Therese,El-Daher ^[3] ; Susan M,Anderson ^[1] ; Sophie C,Glen ^[1] ; Simon,Glerup ^[4] ; Neil O,Carragher ^[2] ; Kathryn L,Evans ^[1]

作者单位： Centre for Genomic & Experimental Medicine, Institute of Genetics & Cancer, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK. ^[1] Cancer Research UK Scotland Centre, Institute of Genetics & Cancer, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK. ^[2] Medical Research Council Human Genetics Unit, Institute of Genetics & Cancer, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK. ^[3] Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark. ^[4]

关键词 Alzheimer’s disease SORL1 drug screen induced-pluripotent stem cell morphological profiling

DOI 10.1093/braincomms/fcae101

PMID 38576795

发布时间 2024-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Brain communications

2024年6卷2期

fcae101页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Morphological profiling in human neural progenitor cells classifies hits in a pilot drug screen for Alzheimer's disease.

Brain communications

相似文献

Brain communications

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Morphological profiling in human neural progenitor cells classifies hits in a pilot drug screen for Alzheimer's disease.

Brain communications

相似文献

Brain communications

相关期刊

检索历史清除